Arete Wealth Advisors LLC lessened its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 42.1% during the 4th quarter, HoldingsChannel reports. The fund owned 4,271 shares of the exchange traded fund’s stock after selling 3,107 shares during the period. Arete Wealth Advisors LLC’s holdings in SPDR S&P Biotech ETF were worth $306,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. Cranbrook Wealth Management LLC acquired a new stake in shares of SPDR S&P Biotech ETF in the 4th quarter worth $26,000. Truewealth LLC acquired a new stake in shares of SPDR S&P Biotech ETF in the 4th quarter worth $29,000. Quattro Financial Advisors LLC lifted its position in SPDR S&P Biotech ETF by 49.6% during the 4th quarter. Quattro Financial Advisors LLC now owns 374 shares of the exchange traded fund’s stock worth $31,000 after acquiring an additional 124 shares during the period. Lehman & Derafelo Financial Resources LLC acquired a new stake in SPDR S&P Biotech ETF during the 4th quarter worth about $32,000. Finally, Essex Savings Bank acquired a new stake in SPDR S&P Biotech ETF during the 4th quarter worth about $120,000.

Shares of XBI opened at $90.33 on Thursday. SPDR S&P Biotech ETF has a one year low of $64.38 and a one year high of $101.55.

WARNING: “Arete Wealth Advisors LLC Sells 3,107 Shares of SPDR S&P Biotech ETF (XBI)” was posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this news story on another site, it was illegally stolen and reposted in violation of United States and international trademark and copyright law. The legal version of this news story can be viewed at https://www.thecerbatgem.com/2019/03/21/arete-wealth-advisors-llc-sells-3107-shares-of-spdr-sp-biotech-etf-xbi.html.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

See Also: Gap Down Stocks

Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI).

Institutional Ownership by Quarter for SPDR S&P Biotech ETF (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.